Events

Back to resource centre

CTAD 2023

  • Date and time

24-27 October 2023

  • Location

Boston, MA (USA)

About this event

The Clinical Trials on Alzheimer’s Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research from Industry and Academia getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.

Meet us

Sessions, presentations & posters

Saturday, July 30 (Technology and Dementia Preconference) and Tuesday, August 2

Saturday, July 30 (Alzheimer’s Imaging Consortium preconference) and Sunday, July 31 (Virtual poster)

Toggle Content

Our latest insights:
15 September 2023
Why don’t we trust people’s lived-experience of fatigue?
30 August 2023
Speech based biomarkers for monitoring progressive changes in Alzheimer’s disease
17 August 2023
The next generation of treatments for Alzheimer’s Disease in clinical trials
07 August 2023
Highlights from AAIC 2023
05 July 2023
Using a multidisciplinary approach to characterise the neurobiology of addiction
31 May 2023
Improvements and personalisation of research and treatment in schizophrenia and psychosis-related disorders; observations from Schizophrenia International Research Society (SIRS) 2023 conference.
Cambridge Cognition
Scroll to Top